glp 1 gip and glucagon GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 Effectiveness, Mechanisms of Action

It has been shown that perilesional melanocytes have a lower ratio of Bcl-2/Bax than control melanocytes, suggesting that melanocytes from patients with vitiligo are more susceptible to apoptosis activation due to altered Bcl-2 and Bax expression and that the balance between pro-apoptotic and anti-apoptotic proteins in vitiligo melanocytes is shifted towards apoptosis [44]

The safety and efficacy of this specific combination have not been directly evaluated by the FDA

Jeff Landry vetoed it

High-fat, greasy, or spicy foods may be more difficult to digest and can exacerbate symptoms

HIF2alpha-arginase axis is essential for the development of pulmonary hypertension

This probably reflects an effort by insurers to deter off-label use of GLP-1s for weight loss